Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort
•Atrioventricular nodal blockers can be safely discontinued after starting mavacamten.•Mavacamten is effective in Asian-American cohorts.•Symptom reduction often occurs at the first visit after initiation.
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2024-04, Vol.216, p.63-65 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 65 |
|---|---|
| container_issue | |
| container_start_page | 63 |
| container_title | The American journal of cardiology |
| container_volume | 216 |
| creator | Benavente, Kevin Moreno, Jesus Pino Banerjee, Dipanjan |
| description | •Atrioventricular nodal blockers can be safely discontinued after starting mavacamten.•Mavacamten is effective in Asian-American cohorts.•Symptom reduction often occurs at the first visit after initiation. |
| doi_str_mv | 10.1016/j.amjcard.2023.11.027 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2894360508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914923013292</els_id><sourcerecordid>2968898414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-e82af6b2a7c99f7eb4ebb76b47464fe23806c8bf9963b87e13bddb69705a6cdd3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EosPAI4AssWGTYOfHsdmgMCoFqdCKH7G0HPum9ZDEg-2E9o14TDydgQUbVtf2_c61fQ5CTynJKaHs5TZX41Yrb_KCFGVOaU6K5h5aUd6IjApa3kcrQkiRCVqJE_QohG3aUlqzh-ik5ITwsuIr9OubjdfGq59qwBc9bqO3boEpFT0PyuOPzqTOm8Hp73a6wu1V6gVsJ3ypor1bfwINdtk3P6hFaTVGmF7hNp1H78IOdLQL4M8JGCDbJAl4fHqzA5_kGvajWnzpwbjRTmqKwy1ug1VT1o4J0WrCG3ftfHyMHvRqCPDkWNfo69vTL5t32fnF2ftNe57pomYxA16onnWFarQQfQNdBV3XsK5qKlb1UKSfM827XghWdrwBWnbGdEw0pFZMG1Ou0YvD3J13P2YIUY42aBgGNYGbgyy4qEpG6uTfGj3_B9262U_pdbIQjHPBK1olqj5QOtkRPPRy5-2o_K2kRO6jlFt5jFLuo5SUyhRl0j07Tp-7Ecxf1Z_sEvD6AECyY7HgZdB3nhrrk-vSOPufK34DJwW1HA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2968898414</pqid></control><display><type>article</type><title>Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Benavente, Kevin ; Moreno, Jesus Pino ; Banerjee, Dipanjan</creator><creatorcontrib>Benavente, Kevin ; Moreno, Jesus Pino ; Banerjee, Dipanjan</creatorcontrib><description>•Atrioventricular nodal blockers can be safely discontinued after starting mavacamten.•Mavacamten is effective in Asian-American cohorts.•Symptom reduction often occurs at the first visit after initiation.</description><identifier>ISSN: 0002-9149</identifier><identifier>ISSN: 1879-1913</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2023.11.027</identifier><identifier>PMID: 38008348</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Asian Americans ; Atrioventricular Block ; AVN blocking agents ; Benzylamines ; Cardiac arrhythmia ; Cardiomyopathy, Hypertrophic ; Ejection fraction ; Hospitalization ; Humans ; hypertrophic cardiomyopathy ; mavacamten ; myosin ; Pacific Islander people ; Patients ; Retrospective Studies ; Uracil - analogs & derivatives</subject><ispartof>The American journal of cardiology, 2024-04, Vol.216, p.63-65</ispartof><rights>2023</rights><rights>Copyright Elsevier Limited Apr 1, 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-e82af6b2a7c99f7eb4ebb76b47464fe23806c8bf9963b87e13bddb69705a6cdd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2968898414?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,46004,64394,64396,64398,72478</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38008348$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Benavente, Kevin</creatorcontrib><creatorcontrib>Moreno, Jesus Pino</creatorcontrib><creatorcontrib>Banerjee, Dipanjan</creatorcontrib><title>Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>•Atrioventricular nodal blockers can be safely discontinued after starting mavacamten.•Mavacamten is effective in Asian-American cohorts.•Symptom reduction often occurs at the first visit after initiation.</description><subject>Asian Americans</subject><subject>Atrioventricular Block</subject><subject>AVN blocking agents</subject><subject>Benzylamines</subject><subject>Cardiac arrhythmia</subject><subject>Cardiomyopathy, Hypertrophic</subject><subject>Ejection fraction</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>hypertrophic cardiomyopathy</subject><subject>mavacamten</subject><subject>myosin</subject><subject>Pacific Islander people</subject><subject>Patients</subject><subject>Retrospective Studies</subject><subject>Uracil - analogs & derivatives</subject><issn>0002-9149</issn><issn>1879-1913</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkc1u1DAUhS0EosPAI4AssWGTYOfHsdmgMCoFqdCKH7G0HPum9ZDEg-2E9o14TDydgQUbVtf2_c61fQ5CTynJKaHs5TZX41Yrb_KCFGVOaU6K5h5aUd6IjApa3kcrQkiRCVqJE_QohG3aUlqzh-ik5ITwsuIr9OubjdfGq59qwBc9bqO3boEpFT0PyuOPzqTOm8Hp73a6wu1V6gVsJ3ypor1bfwINdtk3P6hFaTVGmF7hNp1H78IOdLQL4M8JGCDbJAl4fHqzA5_kGvajWnzpwbjRTmqKwy1ug1VT1o4J0WrCG3ftfHyMHvRqCPDkWNfo69vTL5t32fnF2ftNe57pomYxA16onnWFarQQfQNdBV3XsK5qKlb1UKSfM827XghWdrwBWnbGdEw0pFZMG1Ou0YvD3J13P2YIUY42aBgGNYGbgyy4qEpG6uTfGj3_B9262U_pdbIQjHPBK1olqj5QOtkRPPRy5-2o_K2kRO6jlFt5jFLuo5SUyhRl0j07Tp-7Ecxf1Z_sEvD6AECyY7HgZdB3nhrrk-vSOPufK34DJwW1HA</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Benavente, Kevin</creator><creator>Moreno, Jesus Pino</creator><creator>Banerjee, Dipanjan</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20240401</creationdate><title>Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort</title><author>Benavente, Kevin ; Moreno, Jesus Pino ; Banerjee, Dipanjan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-e82af6b2a7c99f7eb4ebb76b47464fe23806c8bf9963b87e13bddb69705a6cdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Asian Americans</topic><topic>Atrioventricular Block</topic><topic>AVN blocking agents</topic><topic>Benzylamines</topic><topic>Cardiac arrhythmia</topic><topic>Cardiomyopathy, Hypertrophic</topic><topic>Ejection fraction</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>hypertrophic cardiomyopathy</topic><topic>mavacamten</topic><topic>myosin</topic><topic>Pacific Islander people</topic><topic>Patients</topic><topic>Retrospective Studies</topic><topic>Uracil - analogs & derivatives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benavente, Kevin</creatorcontrib><creatorcontrib>Moreno, Jesus Pino</creatorcontrib><creatorcontrib>Banerjee, Dipanjan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benavente, Kevin</au><au>Moreno, Jesus Pino</au><au>Banerjee, Dipanjan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>216</volume><spage>63</spage><epage>65</epage><pages>63-65</pages><issn>0002-9149</issn><issn>1879-1913</issn><eissn>1879-1913</eissn><abstract>•Atrioventricular nodal blockers can be safely discontinued after starting mavacamten.•Mavacamten is effective in Asian-American cohorts.•Symptom reduction often occurs at the first visit after initiation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38008348</pmid><doi>10.1016/j.amjcard.2023.11.027</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2024-04, Vol.216, p.63-65 |
| issn | 0002-9149 1879-1913 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2894360508 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Asian Americans Atrioventricular Block AVN blocking agents Benzylamines Cardiac arrhythmia Cardiomyopathy, Hypertrophic Ejection fraction Hospitalization Humans hypertrophic cardiomyopathy mavacamten myosin Pacific Islander people Patients Retrospective Studies Uracil - analogs & derivatives |
| title | Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T11%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Withdrawal%20Of%20Atrioventricular%20Nodal%20Blocking%20Agents%20in%20Patients%20Receiving%20Mavacamten:%20A%20Retrospective%20Single-Center%20Experience%20in%20A%20Predominantly%20Asian-American%20Cohort&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Benavente,%20Kevin&rft.date=2024-04-01&rft.volume=216&rft.spage=63&rft.epage=65&rft.pages=63-65&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2023.11.027&rft_dat=%3Cproquest_cross%3E2968898414%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2968898414&rft_id=info:pmid/38008348&rft_els_id=S0002914923013292&rfr_iscdi=true |